# TDAP Safety in Pregnant Women

> **NCT02209623** · — · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 375 (actual)

## Conditions studied

- Pertussis

## Interventions

- **BIOLOGICAL:** TDAP

## Key facts

- **NCT ID:** NCT02209623
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** 2017-12-18
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2017-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209623, "TDAP Safety in Pregnant Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02209623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*